BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Z, Dong J, Wu J. Impact of Icariin and its derivatives on inflammatory diseases and relevant signaling pathways. Int Immunopharmacol 2022;108:108861. [PMID: 35597118 DOI: 10.1016/j.intimp.2022.108861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kong Q, Ma M, Zhang L, Liu S, He S, Wu J, Liu B, Dong J. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways. Phytomedicine 2023;110:154638. [PMID: 36621167 DOI: 10.1016/j.phymed.2022.154638] [Reference Citation Analysis]
2 Wang J, Zhu H, Jiang Y, Xiao J, Yang B, Wen L. Fabrication of icariin-soymilk nanoparticles with ultrasound-assisted treatment. Ultrason Sonochem 2022;91:106230. [PMID: 36436486 DOI: 10.1016/j.ultsonch.2022.106230] [Reference Citation Analysis]
3 Meng T, Li X, Li C, Liu J, Chang H, Jiang N, Li J, Zhou Y, Liu Z. Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways. Front Pharmacol 2022;13:997598. [DOI: 10.3389/fphar.2022.997598] [Reference Citation Analysis]
4 He M, Feng R, Wang J, Xia S, Wang Y, Zhang Y. Prevention and treatment of natural products from Traditional Chinese Medicine in depression: Potential targets and mechanisms of action. Front Aging Neurosci 2022;14:950143. [DOI: 10.3389/fnagi.2022.950143] [Reference Citation Analysis]